Acriflavine hydrochloride

In this work, Cu NPs were loaded at a fixed percentage (5 wt%) on 1D, (1D + 0D) and 0D ZnO nanostructures to investigate the effect of the support morphology on the reduction of organic pollutants in water. The synthesized materials were characterized by high-resolution transmission electron microscopy (HR-TEM), ultraviolet-visible spectroscopy (UV-Vis), Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), N2 adsorption-desorption and X-ray photoelectron spectroscopy (XPS). The results reveal that the loading of Cu NPs decreases the optical band gap, and a slight change in the crystallite sizes increases the specific surface area value of the nanocomposites. The TEM images reveal that 1D ZnO has an average width of 44.7 nm and an average length of 211 nm, while 0D ZnO has an average diameter of 54.5 nm. The HR-TEM and XPS data confirm the loading of metallic Cu NPs on the surface of the ZnO nanostructures. The pure ZnO and nanocomposites were tested for 4-nitrophenol (4-NP) reduction in the presence of NaBH4 at room temperature. The obtained results show that pure ZnO nanostructures have no catalytic performance, while the nanocomposites showed good catalytic activities. The catalytic reduction efficiency of 4-NP was found to follow the order of Cu/0DZnO > Cu/(1D + 0D)ZnO > Cu/1DZnO. The complete reduction of 4-NP has been observed to be achievable within 60 s using the Cu/0DZnO nanocomposite, with a k app value of 8.42 min-1 and good recyclability of up to five cycles. This nanocomposite was then applied in the reduction of organic dyes in water; it was found that the reduction rate constants for the methylene blue, Congo red, and acriflavine hydrochloride dyes were 1.4 min-1, 1.2 min-1, and 3.81 min-1, respectively. The high catalytic performance of this nanocomposite may be due to the small particle size, high specific surface area, and the high dispersion of Cu NPs on the surface of ZnO.

Metallic copper nanoparticle (Cu NP)-doped 1D hydroxyapatite was synthesized using a simple chemical reduction method. To describe the structure and composition of the Cu/HAP nanocomposites, physicochemical techniques such as X-ray diffraction, Fourier transform infrared spectroscopy, inductively coupled plasma, N2 adsorption-desorption, X-ray photoelectron spectroscopy, and high-resolution transmission electron microscopy were used. The TEM scan of the Cu/HAP nanocomposite revealed a rod-like shape with 308 nm length and 117 nm width on average. The catalytic activity of Cu/HAP nanocomposites for the reduction of 4-nitrophenol (4-NP) to 4-aminophenol (4-AP) in the presence of NaBH4 has been thoroughly investigated. The 0.7% Cu/HAP nanocomposite was shown to have superior catalytic activity than the other nanocomposites, converting 4-NP to 4-AP in ~1 min with good recyclability. Moreover, this nanocomposite showed excellent catalytic performance in the organic dye reduction such as Congo red and acriflavine hydrochloride dyes. The high dispersion of Cu NPs on HAP support, the high specific surface area, and the small Cu particles contributed to its remarkable catalytic performance.

Helicobacter pylori, a type 1 carcinogen, accounts for numerous gastric cancer-related deaths worldwide. Repurposing existing drugs or developing new ones for a combinatorial approach against increasing antimicrobial resistance is the need of the hour. This study highlights the efficacy of acriflavine hydrochloride (ACF-HCl) in inhibiting the growth of H. pylori reference strain and antibiotic-resistant clinical isolates at low concentrations. ACF-HCl inhibits H. pylori growth at MIC value 10 times less than that in Escherichia coli, another Gram-negative bacteria. Furthermore, ACF-HCl demonstrates synergistic effect with clarithromycin, a commonly used antibiotic against H. pylori. ACF-HCl treatment also eradicates H. pylori infection in the mice model efficiently. Our in vitro data indicate that bacterial membrane is the prime target. The novel action of ACF-HCl against antibiotic-resistant clinical isolates, synergistic effect with the conventional antibiotic clarithromycin and eradication of H. pylori from infected mice highlight the potential of ACF-HCl as a promising therapeutic agent against H. pylori by itself as well as for combinatorial therapy.